Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations

v3.23.2
Statements of Operations - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Total revenue $ 135,167 $ 50,978 $ 135,831 $ 175,986
Total cost of revenue 110,737 50,978 111,401 175,986
Gross profit 24,430 0 24,430 0
Operating expenses:        
Research and development 1,206,688 728,383 2,646,716 1,556,930
General and administrative 933,993 734,637 1,828,926 1,587,586
Sales and marketing 271,900 233,152 576,226 452,581
Total operating expenses 2,412,581 1,696,172 5,051,868 3,597,097
Loss from operations (2,388,151) (1,696,172) (5,027,438) (3,597,097)
Interest income, net 108,345 6,178 219,647 2,462
Net loss $ (2,279,806) $ (1,689,994) $ (4,807,791) $ (3,594,635)
Net loss per share - basic $ (0.37) $ (0.27) $ (0.78) $ (0.58)
Net loss per share - diluted $ (0.37) $ (0.27) $ (0.78) $ (0.58)
Weighted average number of shares outstanding - basic 6,185,397 6,157,625 6,181,972 6,156,495
Weighted average number of shares outstanding - diluted 6,185,397 6,157,625 6,181,972 6,156,495
Development revenue        
Total revenue $ 98,443   $ 98,443  
Total cost of revenue 74,013   74,013  
Grant revenue        
Total revenue 36,724 $ 50,978 37,388 $ 175,986
Total cost of revenue $ 36,724 $ 50,978 $ 37,388 $ 175,986